MicroRNA-218 functions as a tumor suppressor in lung cancer by targeting IL-6/STAT3 and negatively correlates with poor prognosis

[1]  P. Newsholme,et al.  Cancer stem cell metabolism: a potential target for cancer therapy , 2016, Molecular Cancer.

[2]  Alex Boussioutas,et al.  Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients , 2016, Oncotarget.

[3]  X. Chen,et al.  Tumor-suppressive miR-218-5p inhibits cancer cell proliferation and migration via EGFR in non-small cell lung cancer , 2016, Oncotarget.

[4]  Longyun Li,et al.  Downregulation of microRNA-218 relieves neuropathic pain by regulating suppressor of cytokine signaling 3. , 2016, International journal of molecular medicine.

[5]  A. Jemal,et al.  Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.

[6]  J Carl Barrett,et al.  EGFR mutation detection in ctDNA from NSCLC patient plasma: A cross-platform comparison of leading technologies to support the clinical development of AZD9291. , 2015, Lung cancer.

[7]  C. Croce,et al.  MicroRNA-224 promotes tumor progression in nonsmall cell lung cancer , 2015, Proceedings of the National Academy of Sciences.

[8]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[9]  Xiaowei Wang,et al.  miRDB: an online resource for microRNA target prediction and functional annotations , 2014, Nucleic Acids Res..

[10]  S. Jang,et al.  Epigenetic silencing of microRNA-373 to epithelial-mesenchymal transition in non-small cell lung cancer through IRAK2 and LAMP1 axes. , 2014, Cancer letters.

[11]  S. Lawler,et al.  MicroRNAs in cancer: biomarkers, functions and therapy. , 2014, Trends in molecular medicine.

[12]  P. Verde,et al.  miR-340 inhibits tumor cell proliferation and induces apoptosis by targeting multiple negative regulators of p27 in non-small cell lung cancer , 2014, Oncogene.

[13]  H. Saji,et al.  A worldwide trend of increasing primary adenocarcinoma of the lung , 2014, Surgery Today.

[14]  T. Ochiya,et al.  The role of microRNAs in the regulation of cancer stem cells , 2014, Front. Genet..

[15]  Hui Zhou,et al.  starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein–RNA interaction networks from large-scale CLIP-Seq data , 2013, Nucleic Acids Res..

[16]  J. Xiong,et al.  Downregulation of miR‐16 promotes growth and motility by targeting HDGF in non‐small cell lung cancer cells , 2013, FEBS letters.

[17]  Jianming Chen,et al.  MiR-218 sensitizes glioma cells to apoptosis and inhibits tumorigenicity by regulating ECOP-mediated suppression of NF-κB activity. , 2013, Neuro-oncology.

[18]  F. Slack,et al.  miRNA-34 prevents cancer initiation and progression in a therapeutically resistant K-ras and p53-induced mouse model of lung adenocarcinoma. , 2012, Cancer research.

[19]  Jiyun Yang,et al.  MicroRNA-126 Inhibits Tumor Cell Growth and Its Expression Level Correlates with Poor Survival in Non-Small Cell Lung Cancer Patients , 2012, PloS one.

[20]  E. Wang,et al.  SOCS3 expression is inversely correlated with Pyk2 in non-small cell lung cancer and exogenous SOCS3 inhibits proliferation and invasion of A549 cells , 2012, Pathology.

[21]  J. Visvader,et al.  Aldehyde Dehydrogenase Activity Is a Biomarker of Primitive Normal Human Mammary Luminal Cells , 2012, Stem cells.

[22]  Kazuya Kawahara,et al.  miR-218 on the genomic loss region of chromosome 4p15.31 functions as a tumor suppressor in bladder cancer. , 2011, International journal of oncology.

[23]  Jiayuh Lin,et al.  LLL12 inhibits endogenous and exogenous interleukin-6-induced STAT3 phosphorylation in human pancreatic cancer cells. , 2011, Anticancer research.

[24]  Z. Bacso,et al.  miR‐126 inhibits proliferation of small cell lung cancer cells by targeting SLC7A5 , 2011, FEBS letters.

[25]  S. Chiou,et al.  Chemoresistance of lung cancer stemlike cells depends on activation of Hsp27 , 2011, Cancer.

[26]  Cheng-Ta Yang,et al.  Adenovirus-mediated SOCS3 gene transfer inhibits the growth and enhances the radiosensitivity of human non-small cell lung cancer cells. , 2010, Oncology reports.

[27]  Huazong Zeng,et al.  miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc , 2010, Journal of experimental & clinical cancer research : CR.

[28]  Hui Zhou,et al.  starBase: a database for exploring microRNA–mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data , 2010, Nucleic Acids Res..

[29]  E. Olson,et al.  Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. , 2010, Cancer cell.

[30]  Belinda E. Clarke,et al.  MicroRNA-218 Is Deleted and Downregulated in Lung Squamous Cell Carcinoma , 2010, PloS one.

[31]  Alexander Pertsemlidis,et al.  MicroRNA expression distinguishes SCLC from NSCLC lung tumor cells and suggests a possible pathological relationship between SCLCs and NSCLCs , 2010, Journal of experimental & clinical cancer research : CR.

[32]  E. Dmitrovsky,et al.  MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. , 2010, The Journal of clinical investigation.

[33]  D. Fan,et al.  MiR-218 Inhibits Invasion and Metastasis of Gastric Cancer by Targeting the Robo1 Receptor , 2010, PLoS genetics.

[34]  Hansjuerg Alder,et al.  miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. , 2009, Cancer cell.

[35]  C. Croce,et al.  MicroRNAs in Cancer. , 2009, Annual review of medicine.

[36]  F. Monzon,et al.  Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells , 2008, Oncogene.

[37]  Phillip A Sharp,et al.  Suppression of non-small cell lung tumor development by the let-7 microRNA family , 2008, Proceedings of the National Academy of Sciences.

[38]  Michael Kertesz,et al.  The role of site accessibility in microRNA target recognition , 2007, Nature Genetics.

[39]  T Takahashi,et al.  Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92 , 2007, Oncogene.

[40]  C. Croce,et al.  MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.

[41]  Xinmin Cao,et al.  Structure, function, and regulation of STAT proteins. , 2006, Molecular bioSystems.

[42]  M. Meyerson,et al.  Signal transducer and activator of transcription 3 is required for the oncogenic effects of non-small-cell lung cancer-associated mutations of the epidermal growth factor receptor. , 2006, Cancer research.

[43]  Stijn van Dongen,et al.  miRBase: microRNA sequences, targets and gene nomenclature , 2005, Nucleic Acids Res..

[44]  Y. Yatabe,et al.  A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. , 2005, Cancer research.

[45]  K. Gunsalus,et al.  Combinatorial microRNA target predictions , 2005, Nature Genetics.

[46]  C. Burge,et al.  Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.

[47]  V. Ambros.  The functions of animal microRNAs , 2004, Nature.

[48]  Y. Yatabe,et al.  Reduced Expression of the let-7 MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival , 2004, Cancer Research.

[49]  A. Jemal,et al.  Cancer statistics, 2015 , 2015, CA: a cancer journal for clinicians.

[50]  N. Sabri,et al.  Role of STAT3 in lung cancer. , 2014, JAK-STAT.

[51]  J. Shih,et al.  ALDH-positive lung cancer stem cells confer resistance to epidermal growth factor receptor tyrosine kinase inhibitors. , 2013, Cancer letters.

[52]  Wei Wu.  MicroRNA and Cancer , 2011, Methods in Molecular Biology.

[53]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[54]  Li Lin,et al.  A novel small molecule, LLL12, inhibits STAT3 phosphorylation and activities and exhibits potent growth-suppressive activity in human cancer cells. , 2010, Neoplasia.

[55]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[56]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.